CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach

BACKGROUND: Combinatorial immunotherapy strategies for enhancing the responsiveness of immune system have shown great promise for cancer therapy. Engineered nanoformulation incorporated toll-like receptor (TLR) 9 agonist CpG ODN has shown more positive results in suppressing tumor growth and can sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaofei, Hu, Qin, He, Xuesong, Cui, Xinyue, Liang, Zhaoyuan, Wang, Li, Deng, Xiongwei, Zhang, Ze, Sheng, Wang, Han, Xiaodong D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199637/
https://www.ncbi.nlm.nih.gov/pubmed/37208748
http://dx.doi.org/10.1186/s12951-023-01900-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199637/
https://www.ncbi.nlm.nih.gov/pubmed/37208748
http://dx.doi.org/10.1186/s12951-023-01900-8

Ejemplares similares